IBP:NYSEInstalled Building Products, Inc. Analysis
Data as of 2026-08-09 - not real-time
$244.05
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Installed Building Products, Inc. trades at $244.05, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 7.5%. With RSI at 61.8 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at $211.48 and resistance at $253.51.
Valuation screens as overvalued, on a P/E of 26.3 with no clean sector comparison available. Revenue is growing at 2.3% on a 8.5% profit margin. The 0.64% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 37.0%, a beta of 1.30 and a maximum drawdown of 43.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Valuation screens as overvalued, on a P/E of 26.3 with no clean sector comparison available. Revenue is growing at 2.3% on a 8.5% profit margin. The 0.64% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 37.0%, a beta of 1.30 and a maximum drawdown of 43.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for its "Artisan...Building products installation services company Installed Building Products NYSE:IBP reported revenue ahead of Wall...COLUMBUS, Ohio, August 06, 2026--Installed Building Products, Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 262.93
- MACD momentum is positive
- 30-day price change of +7.5%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 262.93
- MACD momentum is positive
- P/E ratio of 26.3
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E ratio of 26.3
- Return on equity of 38.5%
- Dividend yield of 0.64%
Key Metrics & Analysis
Financial Health
Revenue Growth2.30%
Profit Margin8.46%
P/E Ratio26.3
ROE38.45%
ROA10.85%
Debt/Equity187.21
P/B Ratio9.8
Op. Cash Flow$360.0M
Free Cash Flow$289.1M
Technical Analysis
TrendNeutral
RSI61.8
Support$211.48
Resistance$253.51
MA 20$230.11
MA 50$220.52
MA 200$262.93
MACDBullish
VolumeStable
Fear & Greed Index94.82
Valuation
Fair Value$123.54
Target Price$237.55
Upside/Downside-2.67%
GradeOvervalued
TypeBlend
Dividend Yield0.64%
Risk Assessment
Beta1.30
Volatility36.97%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.